A Prospective Nonrandomized Study of Autologous Muscle Derived Cell (AMDC) Transplantation for Treatment of Fecal Incontinence
Phase of Trial: Phase I/II
Latest Information Update: 24 Jul 2019
Price : $35 *
At a glance
- Drugs Autologous muscle-derived stem cell therapy Cook MyoSite (Primary)
- Indications Faecal incontinence
- Focus Adverse reactions
- Sponsors Cook Medical; Cook MyoSite
- 04 Feb 2019 New source identified and integrated (European Clinical Trials Database EudraCT2013-004672-35)
- 16 Jan 2019 Planned End Date changed from 1 Dec 2019 to 1 May 2020.
- 16 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 May 2020.